Detailed studies on the live cell uptake properties of a dinuclear membrane-permeable Ru cell probe show that, at low concentrations, the complex localizes and images mitochondria. At concentrations above ∼20 μM, the complex images nuclear DNA. Because the complex is extremely photostable, has a large Stokes shift, and displays intrinsic subcellular targeting, its compatibility with super-resolution techniques was investigated. It was found to be very well suited to image mitochondria and nuclear chromatin in two color, 2C-SIM, and STED and 3D-STED, both in fixed and live cells. In particular, due to its vastly improved photostability compared to that of conventional SR probes, it can provide images of nuclear DNA at unprecedented resolution.
The synthesis of a new dinuclear complexes containing linked Ru II (dppz) and Re I (dppz) moieties is reported. The photophysical and biological properties of the new complex, which incorporates a N,N'-bis(4-pyridylmethyl)-1,6-hexanediamine tether ligand, are compared to a previously reported Ru II /Re I complex linked by a simple dipyridyl alkane ligand. Although both complexes bind to DNA with similar affinities, steady state and time resolved photophysical studies reveal that the nature of the linker affects the excited state dynamics of the complexes and their DNA photocleavage properties. Quantum based DFT calculations on these systems offers insights into these effects. Whilst both complexes are live cells permeant, their intracellular localization are significantly affected by the nature of the linker. Notably, one of the complexes displayed concentration dependent localization and possesses photophysical properties that are compatible with SIM and STED nanoscopy. This allowed the dynamics of its intracellular localization to be tracked at super resolutions.
Surface engineering of nanocarriers allows fine-tuning of their interactions with biological organisms, potentially forming the basis of devices for the monitoring of intracellular events or for intracellular drug delivery. In this context, biodegradable nanocarriers or nanocapsules capable of carrying bioactive molecules or drugs into the mitochondrial matrix could offer new capabilities in treating mitochondrial diseases. Nanocapsules with a polymeric backbone that undergoes programmed rupture in response to a specific chemical or enzymatic stimulus with subsequent release of the bioactive molecule or drug at mitochondria would be particularly attractive for this function. With this goal in mind, we have developed biologically benign nanocapsules using polyurethane-based, polymeric backbone that incorporates repetitive ester functionalities. The resulting nanocapsules are found to be highly stable and monodispersed in size. Importantly, a new non-isocyanate route is adapted for the synthesis of these non-isocyanate polyurethane nanocapsules (NIPU). The embedded ester linkages of these capsules' shells have facilitated complete degradation of the polymeric backbone in response to a stimulus provided by an esterase enzyme. Hydrophilic payloads like rhodamine or doxorubicin can be loaded inside these nanocarriers during their synthesis by an interfacial polymerization reaction. The postgrafting of the nanocapsules with phosphonium ion, a mitochondria-targeting receptor functionality, has helped us achieve the site-specific release of the drug. Co-localization experiments with commercial mitotracker green as well as mitotracker deep red confirmed localization of the cargo in mitochondria. Our in vitro studies confirm that specific release of doxorubicin within mitochondria causes higher cytotoxicity and cell death compared to free doxorubicin. Endogenous enzyme triggered nanocapsule rupture and release of the encapsulated dye is also demonstrated in a zebrafish model. The results of this proof-of-concept study illustrate that NIPU nanocarriers can provide a site-specific delivery vehicle and improve the therapeutic efficacy of a drug or be used to produce organelle-specific imaging studies.
Using selected transition metal centres and linking ligand “building blocks” a modular approach to the development of cellular imaging agents and therapeutics is discussed and illustrated with examples from research by the Thomas group.
Using a new mononuclear "building block," for the first time, a dinuclear Ru (dppn) complex and a heteroleptic system containing both Ru (dppz) and Ru (dppn) moieties are reported. The complexes, including the mixed dppz/dppn system, are O sensitizers. However, unlike the homoleptic dppn systems, the mixed dppz/dppn complex also displays a luminescence "switch on" DNA light-switch effect. In both cisplatin sensitive and resistant human ovarian carcinoma lines the dinuclear complexes show enhanced uptake compared to their mononuclear analogue. Thanks to a favorable combination of singlet oxygen generation and cellular uptake properties all three of the new complexes are phototoxic and display potent activity against chemotherapeutically resistant cells.
Over
the past 10 years, polyvalent DNA–gold nanoparticle
(DNA–GNP) conjugate has been demonstrated as an efficient,
universal nanocarrier for drug and gene delivery with high uptake
by over 50 different types of primary and cancer cell lines. A barrier
limiting its in vivo effectiveness is limited resistance to nuclease
degradation and nonspecific interaction with blood serum contents.
Herein we show that terminal PEGylation of the complementary DNA strand
hybridized to a polyvalent DNA–GNP conjugate can eliminate
nonspecific adsorption of serum proteins and greatly increases its
resistance against DNase I-based degradation. The PEGylated DNA–GNP
conjugate still retains a high cell uptake property, making it an
attractive intracellular delivery nanocarrier for DNA binding reagents.
We show that it can be used for successful intracellular delivery
of doxorubicin, a widely used clinical cancer chemotherapeutic drug.
Moreover, it can be used for efficient delivery of some cell-membrane-impermeable
reagents such as propidium iodide (a DNA intercalating fluorescent
dye currently limited to the use of staining dead cells only) and
a diruthenium complex (a DNA groove binder), for successful staining
of live cells.
Selective detection of nitroxyl (HNO), which has recently been identified as a reactive nitrogen species, is a challenging task. We report a BODIPY-based luminescence ON reagent for detection of HNO in aqueous solution and in live RAW 264.7 cells, based on the soft nucleophilicity of the phosphine oxide functionality toward HNO. The probe shows high selectivity to HNO over other reactive oxygen/nitrogen and sulfur species. Luminescence properties of the BODIPY-based chemodosimetric reagent make it an ideal candidate for use as a reagent for super-resolution structured illumination microscopy. The viability of the reagent for biological in vivo imaging application was also confirmed using Artemia as a model.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.